Evidence map›Paper›PMID 40277747›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

The Prognostic Role of Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 Expressions in Gastric Carcinomas.

Duygu Ayaz, Gülden Diniz, Ayşe Gül Pulular, Dudu Solakoğlu Kahraman, Umut Varol, Nuket Özkavruk Eliyatkın, Sevil Sayhan, Ali Kemal Kayapınar

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Duygu AyazDepartment of Pathology, İzmir Faculty of Medicine, University of Health Sciences Turkey, İzmir Tepecik Education and Research Hospital, İzmir 35020, Turkey.
Gülden DinizDepartment of Pathology, İzmir Democracy University, Buca Seyfi Demirsoy Hospital, İzmir 35390, Turkey.ORCID 0000-0003-1512-7584
Ayşe Gül PulularDepartment of Pathology, İzmir Democracy University, Buca Seyfi Demirsoy Hospital, İzmir 35390, Turkey.
Dudu Solakoğlu KahramanDepartment of Pathology, İzmir Faculty of Medicine, University of Health Sciences Turkey, İzmir Tepecik Education and Research Hospital, İzmir 35020, Turkey.
Umut VarolDepartment of Medical Oncology, İzmir Democracy University, Buca Seyfi Demirsoy Hospital, İzmir 35390, Turkey.
Nuket Özkavruk EliyatkınDepartment of Pathology, Izmir Katip Çelebi University, Atatürk Education and Research Hospital, İzmir 35360, Turkey.
Sevil SayhanDepartment of Pathology, İzmir Faculty of Medicine, University of Health Sciences Turkey, İzmir Tepecik Education and Research Hospital, İzmir 35020, Turkey.
Ali Kemal KayapınarDepartment of General Surgery, University of Health Sciences Turkey, Izmir City Hospital, İzmir 35540, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaHepatitis A Virus Cellular Receptor 1Lipocalin-2Stomach NeoplasmsAdultAgedBiomarkers, TumorFemaleHumansMaleMiddle AgedPrognosisBiomarkers, TumorHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1LCN2 protein, humanLipocalin-2gastric carcinomasHAVcr-1KIM-1NGALTIM-1

Identifiers

PMID40277747
PMCPMC12026346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.